Nov 25, 2021 by Kody KesterWhy You Should Consider This Blue-Chip Dividend Stock for Your PortfolioT. Rowe Price's average assets under management are steadily growing, and the company remains debt-free.
Nov 25, 2021 by Kody KesterIs Visa a Buy After Its Dividend Hike?Visa delivered strong revenue and earnings growth in fiscal year 2021 in spite of COVID headwinds. And the company could fare even better in the next fiscal year.
Nov 23, 2021 by Kody KesterWhy You Can't Afford Not to Buy Merck's StockThe business continues to perform well, and the stock is unjustifiably cheap.
Nov 23, 2021 by Kody KesterIs This Powerhouse Medical Devices Stock a Buy?Stryker is one of the largest medical device companies in the world, yet it appears to have plenty of growth left in the tank.
Nov 23, 2021 by Kody KesterWhy You Should Consider Buying This Little-Known Medical Devices StockLeMaitre Vascular is a small-cap medical devices maker with the potential to continue growing rapidly in the years ahead.
Nov 22, 2021 by Kody KesterIs This Pharma Stock a Buy?Despite a mixed third-quarter earnings report last month, Eli Lilly's fundamentals appear to still be strong.
Nov 22, 2021 by Kody KesterWhy Bristol Myers Squibb Is a Table-Pounding BuyValue investors can take advantage of the huge discrepancy between the company's valuation and its fundamentals.
Nov 22, 2021 by Kody KesterThis Dividend Aristocrat Just Crushed Earnings Estimates in Q3. Is It a Buy?Depending on your goals as an investor, Aflac could be a dividend stock to help you sleep well at night.
Nov 21, 2021 by Kody KesterShould You Buy This Blue Chip Biotech Stock?AbbVie may be able to provide relief to the income investor struggling to find sanely valued stocks with safe dividends.
Nov 18, 2021 by Kody KesterWhy This Diagnostics Stock Is a BuyQuest Diagnostics beat analysts' estimates in the third quarter and raised its guidance for this year again.
Nov 15, 2021 by Kody Kester3 Reasons VICI Properties Can Easily Afford Its High-Yield DividendInvesting in high-yield dividend stocks requires an investor to watch for the warning signs of an unsustainable payout.
Nov 13, 2021 by Kody Kester3 Top Biotech Stocks to Buy Right NowThese three biotech stocks will do well with a growing and aging customer base in the decades ahead.
Nov 13, 2021 by Kody Kester3 Reasons Why This Tobacco Giant Is a Smoking Hot BuyPhilip Morris International appears as though it could create meaningful wealth for shareholders in the future.
Nov 11, 2021 by Kody KesterBuy This Stock Before It Becomes a Dividend AristocratW.P. Carey is a real estate investment trust with 23 consecutive years of annual dividend increases.
Nov 11, 2021 by Kody Kester5 of the Safest High-Yield Dividend Stocks on the PlanetInvestors need not worry about these stocks, yielding from just over 3% to nearly 9%, being yield traps.
Nov 11, 2021 by Kody Kester3 Best Dividend Stocks to Buy With $500These three dividend stocks each offer safe and growing yields in excess of 3%.
Nov 9, 2021 by Kody Kester3 Dividend Stocks That Should Pay You the Rest of Your LifeAre you in search of stocks whose dividends could outlast you? Here are three stocks to think about purchasing.
Nov 8, 2021 by Kody Kester3 Best Biotech Stocks to Buy in NovemberThese companies could both diversify your portfolio and boost your dividend income.
Nov 8, 2021 by Kody Kester2 Leading Healthcare Stocks to Buy in 2021 and BeyondThese two stocks have secular trends on their side and trade at reasonable valuations.
Nov 6, 2021 by Kody KesterThese Clinical Results Are Good News for AstraZenecaAstraZeneca shared positive interim results for Imfinzi plus chemotherapy in treating patients with advanced biliary tract cancer.
